← Leaderboards
Anna Moore
Massachusetts General Hospital
$29,133,166
Attributed
$34,965,851
Total exposure
20
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,965,851 · 20
By mechanism
R01$22,630,666 · 10
C06$6,721,226 · 1
R21$2,404,193 · 5
R24$1,987,864 · 2
T32$880,850 · 1
S10$341,052 · 1
Top collaborators
- Zdravka O. Medarova12 shared
- Kazuhiko Yamada12 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Zdravka O. Medarova$10,579,501
- Partha Dutta$8,793,128
- Christine Leon Swisher$26,741
Others in their field
Top investigators on “Magnetic Resonance Imaging”
- Michael W Weiner · Northern California Institute Res &Educ$151,227,246
- Paul S. Aisen · Cognition Therapeutics, Inc.$114,102,468
- Reisa A. Sperling · Banner Health$112,709,449
- Randall J Bateman · Washington University$108,056,165
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
Magnetic Resonance ImagingIn VivoMonitorImageNanoparticleBaseAnimalsApoptosisPre-ClinicalEvaluationProtocols DocumentationIsletUptakeDiabeticToxic EffectMouse ModelHistologyMagnetismAnimal ModelIslets Of LangerhansLabelImaging ProbeTransplantationIslet Cell
Grant awards (70)
anti-miR-10b Nanodrug for Treatment of Breast Cancer Metastasis: Study in Companion Animals$568,220
R01 · FY2025 · CA · contact PI
anti-miR-10b Nanodrug for Treatment of Breast Cancer Metastasis: Study in Companion Animals$539,809
R01 · FY2024 · CA · contact PI
anti-miR-10b Nanodrug for Treatment of Breast Cancer Metastasis: Study in Companion Animals$556,856
R01 · FY2023 · CA · contact PI
Novel Prostate cancer therapy based on m-aconitase inhibition$181,084
R21 · FY2023 · CA · contact PI
anti-miR-10b Nanodrug for Treatment of Breast Cancer Metastasis: Study in Companion Animals$556,856
R01 · FY2022 · CA · contact PI
Therapy for Metastatic breast cancer based on micro RNA silencing$555,309
R01 · FY2022 · CA · contact PI
Novel Prostate cancer therapy based on m-aconitase inhibition$235,035
R21 · FY2022 · CA · contact PI
Large Animal Facility for Imaging and Image-guided Therapies at MSU$6,721,226
C06 · FY2021 · OD · contact PI
Therapy for Metastatic breast cancer based on micro RNA silencing$580,298
R01 · FY2021 · CA · contact PI
anti-miR-10b Nanodrug for Treatment of Breast Cancer Metastasis: Study in Companion Animals$568,220
R01 · FY2021 · CA · contact PI
Therapy for Metastatic breast cancer based on micro RNA silencing$586,520
R01 · FY2020 · CA
Therapy for Metastatic breast cancer based on micro RNA silencing$568,924
R01 · FY2019 · CA
siRNA Protection of Composite Islet Kidney Transplant in Baboons$538,002
R01 · FY2019 · DK · contact PI
siRNA Protection of Islet Grafts in Baboons$475,495
R01 · FY2019 · DK · contact PI
Therapy for Metastatic breast cancer based on micro RNA silencing$572,534
R01 · FY2018 · CA
Predictive Cancer Diagnostics and Therapy Response$552,370
R01 · FY2018 · CA · contact PI
siRNA Protection of Composite Islet Kidney Transplant in Baboons$538,002
R01 · FY2018 · DK · contact PI
siRNA Protection of Islet Grafts in Baboons$475,495
R01 · FY2018 · DK · contact PI
Predictive Cancer Diagnostics and Therapy Response$552,368
R01 · FY2017 · CA · contact PI
siRNA Protection of Composite Islet Kidney Transplant in Baboons$473,670
R01 · FY2017 · DK · contact PI
siRNA Protection of Islet Grafts in Baboons$397,132
R01 · FY2017 · DK · contact PI
siRNA Protection of Islet Grafts in Baboons$107,435
R01 · FY2017 · DK · contact PI
siRNA Protection of Composite Islet Kidney Transplant in Baboons$102,094
R01 · FY2017 · DK · contact PI
siRNA Protection of Composite Islet Kidney Transplant in Baboons$592,669
R01 · FY2016 · DK · contact PI
Predictive Cancer Diagnostics and Therapy Response$552,368
R01 · FY2016 · CA · contact PI
siRNA Protection of Islet Grafts in Baboons$523,568
R01 · FY2016 · DK · contact PI
siRNA Protection of Composite Islet Kidney Transplant in Baboons$592,669
R01 · FY2015 · DK · contact PI
Predictive Cancer Diagnostics and Therapy Response$552,368
R01 · FY2015 · CA · contact PI
siRNA Protection of Islet Grafts in Baboons$523,568
R01 · FY2015 · DK · contact PI
Targeted therapy in Type 1 diabetes$670,323
R24 · FY2014 · DK · contact PI
Predictive Cancer Diagnostics and Therapy Response$589,368
R01 · FY2014 · CA · contact PI
Targeted therapy in Type 1 diabetes$682,232
R24 · FY2013 · DK · contact PI
Cancer Imaging$226,777
T32 · FY2013 · CA · contact PI
Cancer Imaging$189,283
T32 · FY2012 · CA · contact PI
Pre-clinical in vivo imaging of islet transplantation in non-human primates$536,195
R01 · FY2011 · DK · contact PI
Multi-Parameter Monitoring of Breast Cancer Progression and Therapeutic Response$488,276
R01 · FY2011 · CA · contact PI
Combined siRNA Therapy and In-vivo Imaging in Islet Transplantation$368,224
R01 · FY2011 · DK · contact PI
Cancer Imaging$206,060
T32 · FY2011 · CA · contact PI
Pre-clinical in vivo imaging of islet transplantation in non-human primates$541,215
R01 · FY2010 · DK · contact PI
Combined siRNA Therapy and In-vivo Imaging in Islet Transplantation$371,943
R01 · FY2010 · DK · contact PI
Cancer Imaging$258,730
T32 · FY2010 · CA · contact PI
Multi-Parameter Monitoring of Breast Cancer Progression and Therapeutic Response$94,933
R01 · FY2010 · CA · contact PI
Combined siRNA Therapy and In-vivo Imaging in Islet Transplantation$51,256
R01 · FY2010 · DK · contact PI
Multi-Parameter Monitoring of Breast Cancer Progression and Therapeutic Response$598,918
R01 · FY2009 · CA · contact PI
Pre-clinical in vivo imaging of islet transplantation in non-human primates$530,362
R01 · FY2009 · DK · contact PI
Combined siRNA Therapy and In-vivo Imaging in Islet Transplantation$374,993
R01 · FY2009 · DK · contact PI
IVIS Spectrum Imaging System$341,052
S10 · FY2009 · RR · contact PI
In-Vivo Imaging of Islet Transplantation$337,685
R01 · FY2009 · DK · contact PI
Multi-Parameter Monitoring of Breast Cancer Progression and Therapeutic Response$616,625
R01 · FY2008 · CA · contact PI
Pre-clinical in vivo imaging of islet transplantation in non-human primates$514,508
R01 · FY2008 · DK · contact PI
Combined siRNA Therapy and In-vivo Imaging in Islet Transplantation$372,874
R01 · FY2008 · DK · contact PI
In-Vivo Imaging of Islet Transplantation$337,685
R01 · FY2008 · DK · contact PI
Imaging of Pancreatic Islet Vasculature: An Interdisciplinary Resource$635,309
R24 · FY2007 · DK · contact PI
Pre-clinical in vivo imaging of islet transplantation in non-human primates$509,307
R01 · FY2007 · DK · contact PI
In-Vivo Imaging of Islet Transplantation$344,577
R01 · FY2007 · DK · contact PI
In vivo Image Guided Cancer Therapy$160,975
R21 · FY2007 · CA · contact PI
Labeling Human Pancreatic Islets for Multi-Modal Imaging$377,906
R21 · FY2006 · DK · contact PI
In-Vivo Imaging of Islet Transplantation$358,531
R01 · FY2006 · DK · contact PI
In vivo imaging of diabetogenic cytotoxic T-lymphocytes$259,334
R01 · FY2006 · DK · contact PI
In vivo Image Guided Cancer Therapy$199,033
R21 · FY2006 · CA · contact PI
Labeling Human Pancreatic Islets for Multi-Modal Imaging$387,000
R21 · FY2005 · DK
In vivo imaging of diabetogenic cytotoxic T-lymphocytes$265,575
R01 · FY2005 · DK
In vivo imaging of diabetogenic cytotoxic T-lymphocytes$265,575
R01 · FY2004 · DK
Novel multi-modal probes for in vivo cancer imaging$259,095
R21 · FY2004 · EB
In vivo imaging of diabetogenic cytotoxic T-lymphocytes$353,888
R01 · FY2003 · DK
Novel multi-modal probes for in vivo cancer imaging$259,095
R21 · FY2003 · EB
In Vivo Imaging of Autoimmune Attack in Type 1 Diabetes$173,000
R01 · FY2003 · DK
In Vivo Imaging of Autoimmune Attack in Type 1 Diabetes$173,000
R01 · FY2002 · DK
MEASURING OF PANCREATIC BETA-CELL MASS BY IMAGING$172,485
R21 · FY2001 · DK
MEASURING OF PANCREATIC BETA-CELL MASS BY IMAGING$172,485
R21 · FY2000 · DK